Sunshine Biopharma Inc Warrant
SBFMW
3 hedge funds and large institutions have $2.57K invested in Sunshine Biopharma Inc Warrant in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
200% more funds holding
Funds holding: 1 → 3 (+2)
44% more capital invested
Capital invested by funds: $1.79K → $2.57K (+$782)
1.34% more ownership
Funds ownership: 0.78% → 2.12% (+1.3%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$3.98K |
| 2 |
CS
Clear Street
New York
|
+$34 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$908 |
SBFMW Hedge Fund Activity: Q2 2026 in Review
3 of the 8,343 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q2 2026, worth a combined $2.57K — up 44% from $1.79K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SBFMW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $3.98K. The largest seller was UBS Group, cutting an estimated $908.
- 3 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q2 2026, up from 1 in Q1 2026.
- Funds reported $2.57K of Sunshine Biopharma Inc Warrant stock for Q2 2026, up 44% quarter-over-quarter.
- 2 funds opened new Sunshine Biopharma Inc Warrant positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest Sunshine Biopharma Inc Warrant buyer in Q2 2026 was HRT Financial, an estimated $3.98K added.
- The largest Sunshine Biopharma Inc Warrant seller in Q2 2026 was UBS Group, an estimated $908 sold.
Based on aggregated 13F filings for Q2 2026.